Gene · 3817
Papers1,753
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,753
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A model for the human fetal ventricular myocyte electrophysiology. | PLoS Comput Biol | 2026 | 41592129 | PubTator, text mining | PubMed |
| The making of multispecific immunoglobulins - a clinical perspective. | MAbs | 2026 | 41542910 | PubTator, text mining | PubMed |
| Current and future perspectives on radioligand therapy in advanced prostate cancer. | Ther Adv Med Oncol | 2026 | 41536963 | PubTator, text mining | PubMed |
| Inhibition of Growth and Induction of Apoptosis of Human Prostate Cancer Cells by Enzymatic Blockage of Kallikreins. | Prostate Cancer | 2026 | 41531507 | PubTator, text mining | PubMed |
| Mechanisms of rectified gap junctional coupling enhancing pacemaking activity of biologically engineered pacemaker cells. | NPJ Syst Biol Appl | 2026 | 41526358 | PubTator, text mining | PubMed |
| Identification of Susceptibility Genes for Hypertension in the Dong Ethnic Population of Tongdao. | Biochem Genet | 2026 | 41507431 | PubTator, text mining | PubMed |
| Genetic variations in extracellular matrix degradation pathways linking to major depressive disorder: Evidence from a large-scale genetic association study. | Biomedicine (Taipei) | 2025 | 41523645 | PubTator, text mining | PubMed |
| Advances in Non-Small Cell Lung Cancer Cellular Immunotherapy: A Progress in Dendritic Cell, T-Cell, and NK Cell Vaccines. | Cells | 2025 | 41002418 | PubTator, text mining | PubMed |
| Prostate Cancer Immunotherapy: Time to Move Beyond Checkpoint Inhibitors. | Immunotargets Ther | 2025 | 40970252 | PubTator, text mining | PubMed |
| Drug Targets in Prostate Cancer: An Appetite for KLK2-Mediated Destruction. | Clin Cancer Res | 2025 | 40924642 | PubTator, text mining | PubMed |
| A secreted signature discriminates indolent from aggressive prostate tumors. | World J Urol | 2025 | 40839223 | PubTator, text mining | PubMed |
| PCP4 inhibits the progression of prostate cancer through Ca2+/CAMKK2/AMPK/AR pathway. | Front Immunol | 2025 | 40746562 | PubTator, text mining | PubMed |
| Shared epitopes create safety and efficacy concerns in several cancer vaccines. | J Immunother Cancer | 2025 | 40645662 | PubTator, text mining | PubMed |
| Human Kallikrein 2: A Novel Lineage-Specific Surface Target in Prostate Cancer. | Clin Cancer Res | 2025 | 40627156 | PubTator, text mining | PubMed |
| Pasritamig, a First-in-Class, Bispecific T-Cell Engager Targeting Human Kallikrein 2, in Metastatic Castration-Resistant Prostate Cancer: A Phase I Study. | J Clin Oncol | 2025 | 40450573 | PubTator, text mining | PubMed |
| Protein Manipulation via Dielectrophoresis: Theoretical Principles and Emerging Microfluidic Platforms. | Micromachines (Basel) | 2025 | 40428658 | PubTator, text mining | PubMed |
| TCR-Based Therapy Directed against Kallikrein-Related Peptidase 4 Is Safe and Effective against Prostate Cancer. | Cancer Immunol Res | 2025 | 40387827 | PubTator, text mining | PubMed |
| Structure-based identification of bioactive phytochemicals targeting kallikrein-related peptidase 2 for prostate cancer therapy. | Front Chem | 2025 | 40207180 | PubTator, text mining | PubMed |
| Identification and characterization of mitochondrial autophagy-related genes in osteosarcoma and predicting clinical prognosis. | Sci Rep | 2025 | 40128298 | PubTator, text mining | PubMed |
| Construction of a prognostic risk model for clear cell renal cell carcinomas based on centrosome amplification-related genes. | Mol Genet Genomics | 2025 | 40075035 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3817/papers?page=2